Systemic and portal hemodynamic effects of anandamide

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 280, Issue 1 43-1, 2001, Pages

  Garcia Jr , Nelson ^a   Járai, Zoltán ^a   Mirshahi, Faridoddin ^a   Kunos, George ^a   Sanyal, Arun J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Cannabinoids; Cirrhosis; Portal hypertension; Portal vein flow; Portal vein pressure; Splanchnic blood flow; SR 141716A

Indexed keywords

ANANDAMIDE; ARACHIDONATE 5 LIPOXYGENASE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NORDIHYDROGUAIARETIC ACID; PROSTAGLANDIN SYNTHASE; RIMONABANT;

ANIMAL EXPERIMENT; ARTERY DILATATION; ARTICLE; DOSE RESPONSE; DRUG EFFECT; HEART OUTPUT; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; NONHUMAN; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT; SYSTEMIC CIRCULATION; VASCULAR RESISTANCE;

EID: 0343831464     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2001.280.1.g14     Document Type: Article

References (29)

1. Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, Pertwee RG, and Makriyannis A. (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J Med Chem 37: 1889-1893, 1994.
2. Bloom AS, Tershner S, Fuller SA, and Stein EA. Cannabinoid-induced alterations in regional cerebral blood flow in the rat. Pharmacol Biochem Behav 57: 625-631, 1997.
3. Brackett DJ, Schaefer CF, Tompkins P, Fagraeus L, Peters LJ, and Wilson MF. Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock 17: 273-284, 1985.
4. 2+-induced relaxation of isolated arteries. Hypertension 30: 1431-1439, 1997.
5. Deutsch DG, Goligorsky MS, Schmid PC, Krebsbach RJ, Schmid HH, Das SK, Dey SK, Arreaza G, Thorup C, Stefano G, and Moore LC. Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest 100: 1538-1546, 1997.
6. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949, 1992.
7. Dewey WL, Harris LS, Howes JF, Kennedy JS, Granchelli FE, Pars HG, and Razdan RK. Pharmacology of some marijuana constituents and 2 heterocyclic analogues. Nature 226: 1265-1267, 1970.
8. Fernandez M, Garcia-Pagan JC, Casadevall M, Mourelle MI, Pique JM, Bosch J, and Rodes J. Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis. Gastroenterology 110: 1529-1535, 1996.
9. Groszmann RJ. Hyperdynamic state in chronic liver diseases. J Hepatol 17, Suppl 2: S38-S40, 1993.
10. Gupta TK, Chen L, and Groszmann RJ. Pathophysiology of portal hypertension. Clin Liver Dis 1: 1-12, 1997.
11. 2+-induced relaxation. J Pharmacol Exp Ther 289: 245-250, 1999.
12. Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, and Kunos G. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA 96: 14136-14141, 1999.
13. Lake KD, Compton DR, Varga K, Martin BR, and Kunos G. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors. J Pharmacol Exp Ther 281: 1030-1037, 1997.
14. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, and Parmentier M. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283: 401-404, 1999.
15. Lee SS, Girod C, Valla D, Geoffroy P, and Lebrec D. Effects of pentobarbital sodium anesthesia on splanchnic hemodynamics of normal and portal-hypertensive rats. Am J Physiol Gastrointest Liver Physiol 249: G528-G532, 1985.
16. Liu J, Mirshahi F, Sanyal AJ, Khanolkar AD, Makriyannis A, and Kunos G. Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J 346: 835-840, 2000.
17. Malinowska B, Godlewski G, Bucher B, and Schlicker E. Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat. Naunyn Schmiedebergs Arch Pharmacol 356: 197-202, 1997.
18. Mathew RJ, Wilson WH, Coleman RE, Turkington TG, and Degrado TR. Marijuana intoxication and brain activation in marijuana smokers. Life Sci 60: 2075-2089, 1997.
19. Moncada S and Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993.
20. Oberti F, Sogni P, Cailmail S, Moreau R, Pipy B, and Lebrec D. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension. Hepatology 18: 621-627, 1993.
21. Pannen BH and Bauer M. Differential regulation of hepatic arterial and portal venous vascular resistance by nitric oxide and carbon monoxide in rats. Life Sci 62: 2025-2033, 1998.
22. Randall MD, McCulloch AI, and Kendall DA. Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery. Eur J Pharmacol 333: 191-197, 1997.
23. Varga K, Lake KD, Huangfu D, Guyenet PG, and Kunos G. Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 28: 682-686, 1996.
24. Varga K, Lake K, Martin BR, and Kunos G. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 278: 279-283, 1995.
25. Varga K, Wagner JA, Bridgen DT, and Kunos G. Platelet-and macropahage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 12: 1035-1044, 1998.
26. Vidrio H, Sanchez-Salvatori MA, and Medina M. Cardiovascular effects of (-)-11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl in rats. J Cardiovasc Pharmacol 28: 332-336, 1996.
27. Wagner JA, Varga K, Ellis EF, Rzigalinski BA, Martin BR, and Kunos G. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature 390: 518-521, 1997.
28. Wagner JA, Varga K, Jarai Z, and Kunos G. Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 33: 429-434, 1999.
29. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di M, Julius DV, and Hogestatt ED. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400: 452-457, 1999.